Suchergebnisse - "Oluwole, Olalekan O"

PubPharm (4)

1

Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States : incorporating longer survival results

enthalten in: Journal of medical economics | 2024

von Oluwole, O. | Ray, M. | Davies, N. | +4

2

An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States

enthalten in: Journal of medical economics | 2024

von Oluwole, O. | Patel, A. | Vadgama, S. | +6

3

Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the US

enthalten in: Journal of medical economics | 2022

von Oluwole, O. | Liu, R. | Diakite, I. | +5

4

Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States

enthalten in: Journal of medical economics | 2021

von Liu, R. | Oluwole, O. | Diakite, I. | +3

1
[1]